P532 Efficacy of combination therapy with cyclosporin and vedolizumab in inflammatory bowel diseases refractory to anti-TNF agents

Authors :: T Molnár
Ágnes Milassin
Zoltán Szepes
Anita Bálint
Klaudia Farkas
Anna Fábián
Kata Szántó
Mariann Rutka
Renáta Bor
Source :: Journal of Crohn's and Colitis. 12:S375-S375
Publication Year :: 2018
Publisher :: Oxford University Press (OUP), 2018.

Subjects :: medicine.medical_specialty
Combination therapy
business.industry
Gastroenterology
Inflammatory Bowel Diseases
General Medicine
Vedolizumab
Refractory
Internal medicine
medicine
Tumor necrosis factor alpha
business
medicine.drug

Full Text Access

Tools